These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35128348)
1. Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions. Koşaloğlu-Yalçın Z; Lee J; Greenbaum J; Schoenberger SP; Miller A; Kim YJ; Sette A; Nielsen M; Peters B iScience; 2022 Feb; 25(2):103850. PubMed ID: 35128348 [TBL] [Abstract][Full Text] [Related]
2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B Front Immunol; 2018; 9():1795. PubMed ID: 30127785 [TBL] [Abstract][Full Text] [Related]
3. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system. Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790 [TBL] [Abstract][Full Text] [Related]
4. Footprints of antigen processing boost MHC class II natural ligand predictions. Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001 [TBL] [Abstract][Full Text] [Related]
5. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data. Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519 [TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex linked databases and prediction tools for designing vaccines. Singh SP; Mishra BN Hum Immunol; 2016 Mar; 77(3):295-306. PubMed ID: 26585361 [TBL] [Abstract][Full Text] [Related]
7. MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing. O'Donnell TJ; Rubinsteyn A; Laserson U Cell Syst; 2020 Jul; 11(1):42-48.e7. PubMed ID: 32711842 [TBL] [Abstract][Full Text] [Related]
8. Estimating tissue-specific peptide abundance from public RNA-Seq data. Frentzen A; Greenbaum JA; Kim H; Peters B; Koşaloğlu-Yalçın Z Front Genet; 2023; 14():1082168. PubMed ID: 36713080 [TBL] [Abstract][Full Text] [Related]
9. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes. Zhao W; Sher X PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041 [TBL] [Abstract][Full Text] [Related]
10. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data. Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001 [TBL] [Abstract][Full Text] [Related]
11. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Stranzl T; Larsen MV; Lundegaard C; Nielsen M Immunogenetics; 2010 Jun; 62(6):357-68. PubMed ID: 20379710 [TBL] [Abstract][Full Text] [Related]
12. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data. Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689 [TBL] [Abstract][Full Text] [Related]
13. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. Wang P; Sidney J; Dow C; Mothé B; Sette A; Peters B PLoS Comput Biol; 2008 Apr; 4(4):e1000048. PubMed ID: 18389056 [TBL] [Abstract][Full Text] [Related]
14. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes. Bordner AJ PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956 [TBL] [Abstract][Full Text] [Related]
19. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes. Jørgensen KW; Buus S; Nielsen M PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859 [TBL] [Abstract][Full Text] [Related]
20. MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. Rozanov DV; Rozanov ND; Chiotti KE; Reddy A; Wilmarth PA; David LL; Cha SW; Woo S; Pevzner P; Bafna V; Burrows GG; Rantala JK; Levin T; Anur P; Johnson-Camacho K; Tabatabaei S; Munson DJ; Bruno TC; Slansky JE; Kappler JW; Hirano N; Boegel S; Fox BA; Egelston C; Simons DL; Jimenez G; Lee PP; Gray JW; Spellman PT J Proteomics; 2018 Mar; 176():13-23. PubMed ID: 29331515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]